BioSpace News Archive

Cuidalas is a Cure Latam project that was born with the vision of improving the well-being and health of Colombian women, contributing to the early detection of breast cancer thanks to iBreastExam (iBE) certified technology, knowing awareness of social responsibility that each person has to take care of the health of their loved ones and also their own.

Celldex Therapeutics, Inc. today announced new data from the Company’s open label Phase 1b clinical trial of barzolvolimab in patients with antihistamine refractory chronic inducible urticarias are being presented at the GA²LEN Global Urticaria Forum (GUF) held in Berlin, Germany.

Acutus Medical, Inc. today announced receipt of a CE Mark issued under the European Union (EU) Medical Device Regulations (MDR) for its AcQMap 3D Imaging and Mapping Catheter, the world’s only integrated high-resolution ultrasound imaging and non-contact mapping catheter.

Ocuphire Pharma, Inc. today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Phentolamine Ophthalmic Solution 0.75% (Nyxol ® ) for the reversal of pharmacologically-induced mydriasis (RM).

Karuna Therapeutics, Inc. today announced the appointment of Bill Meury as president and chief executive officer (CEO) and a member of the Company’s board, effective January 3, 2023.

BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based therapies, today announced that it has been awarded a Small Business Innovation Research (SBIR) Phase I grant from the Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health.

Agios Pharmaceuticals, Inc. today announced the appointment of Tsveta Milanova to the role of chief commercial officer, effective Jan. 3, 2023.

Lucira Health, Inc. and Loch Lomond Villa announced today a clinical study to simultaneously test residents, medical and support staff, and visitors for COVID-19 and Influenza A/B infection with the Lucira COVID-19 & Flu Test.

OnKure, Inc. today announced the appointment of Roberta (“Robbie”) Alton, Pharm., as Vice President of Clinical Operations.

Tiziana Life Sciences Ltd. today announced that the 2022 Annual General Meeting of the Company will be held on December 29, 2022.